[HTML][HTML] Pathogenesis and treatment options of cancer related anemia: perspective for a targeted mechanism-based approach
C Madeddu, G Gramignano, G Astara… - Frontiers in …, 2018 - frontiersin.org
Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
[PDF][PDF] Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
C Madeddu, G Gramignano, G Astara, R Demontis… - academia.edu
Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
[HTML][HTML] Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
C Madeddu, G Gramignano, G Astara… - Frontiers in …, 2018 - ncbi.nlm.nih.gov
Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach.
C Madeddu, G Gramignano, G Astara… - Frontiers in …, 2018 - europepmc.org
Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
C Madeddu, G Gramignano, G Astara… - FRONTIERS IN …, 2018 - iris.unica.it
Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
[引用][C] Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
C Madeddu, G Gramignano, G Astara… - … in Physiology (Web), 2018 - jglobal.jst.go.jp
Aapro M., Osterwalder B., Scherhag A., Burger HU (2009). Epoetin-beta treatment in patients
with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target …
with cancer chemotherapy-induced anaemia: the impact of initial haemoglobin and target …
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
C Madeddu, G Gramignano, G Astara… - Frontiers in …, 2018 - pubmed.ncbi.nlm.nih.gov
Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
[引用][C] Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
C Madeddu, G Gramignano, G Astara… - Frontiers in …, 2018 - cir.nii.ac.jp
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted
Mechanism-Based Approach | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Mechanism-Based Approach | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach.
C Madeddu, G Gramignano, G Astara… - Frontiers in …, 2018 - europepmc.org
Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
[PDF][PDF] Pathogenesis and Treatment Options of Cancer Related Anemia: Perspective for a Targeted Mechanism-Based Approach
C Madeddu, G Gramignano, G Astara, R Demontis… - iris.unica.it
Cancer-related anemia (CRA) is a common sign occurring in more than 30% of cancer
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …
patients at diagnosis before the initiation of antineoplastic therapy. CRA has a relevant …